Literature DB >> 25745009

Complete Sequence of Probiotic Symbioflor 2 Escherichia coli Strain G3/10 and Draft Sequences of Symbioflor 2 E. coli Strains G1/2, G4/9, G5, G6/7, and G8.

Anke Zschüttig1, Christian Auerbach1, Simone Meltke1, Christin Eichhorn1, Manuela Brandt1, Jochen Blom2, Alexander Goesmann2, Michael Jarek3, Maren Scharfe3, Kurt Zimmermann4, Trudy M Wassenaar5, Florian Gunzer6.   

Abstract

The complete genome of probiotic Escherichia coli strain G3/10 is presented here. In addition, the probiotic E. coli strains G1/2, G4/9, G5, G6/7, and G8 are presented in draft form. These six strains together comprise the probiotic product Symbioflor 2 (DSM 17252).
Copyright © 2015 Zschüttig et al.

Entities:  

Year:  2015        PMID: 25745009      PMCID: PMC4358396          DOI: 10.1128/genomeA.01330-14

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Although probiotic activity is more often associated with lactic acid bacteria, some Escherichia coli strains have also been shown to have beneficial effects on human health. We consider it an essential step in the safety evaluation of probiotics to analyze their complete genomic content. The six probiotic E. coli strains presented here are all components of the probiotic product Symbioflor 2 (DSM 17252), provided by SymbioPharm (Herborn, Germany). The product is recommended for the treatment of irritable bowel syndrome (IBS) in adults and children (1, 2). The E. coli strains comprising Symbioflor 2 were originally isolated from a single healthy human donor and stored separately since their isolation in 1956. Based on decades of experience of clinical use in humans, and in the absence of severe adverse reactions, Symbioflor 2 can be considered safe. In February 2011, all six Symbioflor 2 E. coli strains were assigned to risk group 1 by the Central Committee on Biological Safety (ZKBS) of the German Federal Office of Consumer Protection and Food Safety (BVL). The genome of E. coli G3/10 was sequenced at CeBiTec (University of Bielefeld, Bielefeld, Germany) using the Roche 454 Genome Sequencer FLX system (Roche Diagnostics, Mannheim, Germany). Its chromosome was initially assembled into ~190 contigs, flanked by repeated rrn loci, which were assembled into four large scaffolds, using the GS de novo assembler. Eight contigs with a total size of about 64 kb could not be assembled into any of these scaffolds. Gap closure on the scaffolds was performed by the sequencing of PCR products amplified with terminal primers and fosmid walking, resulting in four contiguous finished sequences. The three gaps between these sequences could not be closed by PCR. The strain contains one 50-kb plasmid and five smaller plasmids (Table 1). The other Symbioflor 2 E. coli strains, G1/2, G4/9, G5, G6/7, and G8, were sequenced at the Helmholtz Centre for Infection Research (Braunschweig, Germany) using the Genome Analyzer IIx (Illumina, San Diego, CA, USA). These strains contain between 1 and 5 plasmids (Table 1). De novo assembly was performed with Velvet (3). Gap closure was achieved by sequencing the PCR products generated with terminal primers.
TABLE 1

Characteristics of the six genomes

E. coli strain (DSMZ no.)aChromosome size (bp)No. of contigsAccession no.bPlasmid(s) (size [bp])Accession no.
G1/2 (DSM 16441)5,090,326252JPKH00000000pSYM10 (1,549), pSYM12 (7,111)KM107846 (pSYM10), KM107848 (pSYM12)
G3/10 (DSM 16443)4,999,26712JPKI00000000pSYM1 (50,572), pSYM2 (4,197), pSYM3 (1,934), pSYM4 (1,304), pSYM5 (6,567), pSYM6 (10,433)JN887338 (pSYM1), KM107838 (pSYM2), KM107839 (pSYM3), KM107840 (pSYM4), KM107841 (pSYM5), KM107842 (pSYM6)
G4/9 (DSM 16444)4,545,81879JPKJ00000000pSYM4
G5 (DSM 16445)4,787,583151JPKK00000000pSYM3, pSYM7 (4,452), pSYM8 (2,353), pSYM9 (12,686), pSYM11 (3,215)KM107843 (pSYM7), KM107844 (pSYM8), KM107845 (pSYM9), KM107847 (pSYM11)
G6/7 (DSM 16446)5,236,262185JPMZ00000000pSYM10, pSYM12
G8 (DSM 16448)5,160,208300JPKL00000000pSYM10, pSYM12

Strain number in the Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany.

The contigs are merged into a single accession number.

Characteristics of the six genomes Strain number in the Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany. The contigs are merged into a single accession number. The annotation of open reading frames (identified in the genomes by various automated protocols) was performed using the GenDB 2.4 annotation pipeline (4). tRNA genes were predicted using tRNAscan (5). The automated annotation was revised by BLAST analysis (6) using publicly available databases. The Symbioflor 2 strains G6/7 and G8 are closely related and may have originated from the same clone, as few differences were detected between the two draft genome sequences. Of note is the production of microcin S by E. coli G3/10, a microcin encoded by a plasmid-carried operon (7). Microcins are peptides that function as bacteriocins against closely related species (8), and microcin S of strain G3/10 may play a role in its probiotic activity.

Nucleotide sequence accession numbers.

This whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession numbers given in Table 1. The version described in this paper is the first version.
  8 in total

1.  GenDB--an open source genome annotation system for prokaryote genomes.

Authors:  Folker Meyer; Alexander Goesmann; Alice C McHardy; Daniela Bartels; Thomas Bekel; Jörn Clausen; Jörn Kalinowski; Burkhard Linke; Oliver Rupp; Robert Giegerich; Alfred Pühler
Journal:  Nucleic Acids Res       Date:  2003-04-15       Impact factor: 16.971

2.  Basic local alignment search tool.

Authors:  S F Altschul; W Gish; W Miller; E W Myers; D J Lipman
Journal:  J Mol Biol       Date:  1990-10-05       Impact factor: 5.469

Review 3.  Microcins, gene-encoded antibacterial peptides from enterobacteria.

Authors:  Sophie Duquesne; Delphine Destoumieux-Garzón; Jean Peduzzi; Sylvie Rebuffat
Journal:  Nat Prod Rep       Date:  2007-04-18       Impact factor: 13.423

4.  Velvet: algorithms for de novo short read assembly using de Bruijn graphs.

Authors:  Daniel R Zerbino; Ewan Birney
Journal:  Genome Res       Date:  2008-03-18       Impact factor: 9.043

5.  Probiotic treatment of irritable bowel syndrome in children.

Authors:  U Martens; P Enck; E Zieseniss
Journal:  Ger Med Sci       Date:  2010-03-02

6.  Randomized controlled treatment trial of irritable bowel syndrome with a probiotic E.-coli preparation (DSM17252) compared to placebo.

Authors:  P Enck; K Zimmermann; G Menke; S Klosterhalfen
Journal:  Z Gastroenterol       Date:  2009-02-05       Impact factor: 2.000

7.  Identification and characterization of microcin S, a new antibacterial peptide produced by probiotic Escherichia coli G3/10.

Authors:  Anke Zschüttig; Kurt Zimmermann; Jochen Blom; Alexander Goesmann; Christoph Pöhlmann; Florian Gunzer
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

8.  The tRNAscan-SE, snoscan and snoGPS web servers for the detection of tRNAs and snoRNAs.

Authors:  Peter Schattner; Angela N Brooks; Todd M Lowe
Journal:  Nucleic Acids Res       Date:  2005-07-01       Impact factor: 16.971

  8 in total
  9 in total

1.  Virulence genes in a probiotic E. coli product with a recorded long history of safe use.

Authors:  Trudy M Wassenaar; Anke Zschüttig; Claudia Beimfohr; Thomas Geske; Christian Auerbach; Helen Cook; Kurt Zimmermann; Florian Gunzer
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2015-03-26

2.  Therapy of solid tumors using probiotic Symbioflor-2: restraints and potential.

Authors:  Dino Kocijancic; Sebastian Felgner; Michael Frahm; Ronja-Melinda Komoll; Aida Iljazovic; Vinay Pawar; Manfred Rohde; Ulrike Heise; Kurt Zimmermann; Florian Gunzer; Juliane Hammer; Katja Crull; Sara Leschner; Siegfried Weiss
Journal:  Oncotarget       Date:  2016-04-19

Review 3.  A Review of Research Conducted with Probiotic E. coli Marketed as Symbioflor.

Authors:  Claudia Beimfohr
Journal:  Int J Bacteriol       Date:  2016-11-22

4.  Engineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy.

Authors:  Sebastian Felgner; Dino Kocijancic; Michael Frahm; Ulrike Heise; Manfred Rohde; Kurt Zimmermann; Christine Falk; Marc Erhardt; Siegfried Weiss
Journal:  Oncoimmunology       Date:  2017-10-16       Impact factor: 8.110

Review 5.  Insights from 100 Years of Research with Probiotic E. Coli.

Authors:  Trudy M Wassenaar
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2016-09-29

Review 6.  Microcins in Enterobacteriaceae: Peptide Antimicrobials in the Eco-Active Intestinal Chemosphere.

Authors:  Fernando Baquero; Val F Lanza; Maria-Rosario Baquero; Rosa Del Campo; Daniel A Bravo-Vázquez
Journal:  Front Microbiol       Date:  2019-10-09       Impact factor: 5.640

7.  Bacteriocin Occurrence and Activity in Escherichia coli Isolated from Bovines and Wastewater.

Authors:  Andrew Cameron; Rahat Zaheer; Emelia H Adator; Ruth Barbieri; Tim Reuter; Tim A McAllister
Journal:  Toxins (Basel)       Date:  2019-08-15       Impact factor: 4.546

Review 8.  Colicins and Microcins Produced by Enterobacteriaceae: Characterization, Mode of Action, and Putative Applications.

Authors:  Katarina G Marković; Mirjana Ž Grujović; Maja G Koraćević; Danijela D Nikodijević; Milena G Milutinović; Teresa Semedo-Lemsaddek; Milan D Djilas
Journal:  Int J Environ Res Public Health       Date:  2022-09-19       Impact factor: 4.614

9.  Symbioflor2® Escherichia coli Genotypes Enhance Ileal and Colonic Gene Expression Associated with Mucosal Defense in Gnotobiotic Mice.

Authors:  Unai Escribano-Vazquez; Claudia Beimfohr; Deborah Bellet; Muriel Thomas; Kurt Zimmermann; Philippe Langella; Claire Cherbuy
Journal:  Microorganisms       Date:  2020-04-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.